Cas no 2223032-20-8 (2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical and Physical Properties
Names and Identifiers
-
- 2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
- 2223032-20-8
- EN300-1425806
- Z2181849758
- AT33162
-
- Inchi: 1S/C12H19BO2S/c1-6-10-7-9(8-16-10)13-14-11(2,3)12(4,5)15-13/h7-8H,6H2,1-5H3
- InChI Key: MXXQMXIFGBDGMH-UHFFFAOYSA-N
- SMILES: S1C(CC)=CC(B2OC(C)(C)C(C)(C)O2)=C1
Computed Properties
- Exact Mass: 238.1198812 g/mol
- Monoisotopic Mass: 238.1198812 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 16
- Rotatable Bond Count: 2
- Complexity: 252
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Molecular Weight: 238.16
- Topological Polar Surface Area: 46.7
2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | E907839-100mg |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95% | 100mg |
13,440.00 | 2021-05-17 | |
| Enamine | EN300-1425806-50mg |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95.0% | 50mg |
$315.0 | 2023-09-30 | |
| Enamine | EN300-1425806-100mg |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95.0% | 100mg |
$470.0 | 2023-09-30 | |
| Enamine | EN300-1425806-250mg |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95.0% | 250mg |
$672.0 | 2023-09-30 | |
| Enamine | EN300-1425806-500mg |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95.0% | 500mg |
$1058.0 | 2023-09-30 | |
| Enamine | EN300-1425806-1000mg |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95.0% | 1000mg |
$1357.0 | 2023-09-30 | |
| Enamine | EN300-1425806-2500mg |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95.0% | 2500mg |
$2660.0 | 2023-09-30 | |
| Enamine | EN300-1425806-5000mg |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95.0% | 5000mg |
$3935.0 | 2023-09-30 | |
| Enamine | EN300-1425806-10000mg |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95.0% | 10000mg |
$5837.0 | 2023-09-30 | |
| Enamine | EN300-1425806-0.05g |
2-(5-ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2223032-20-8 | 95% | 0.05g |
$315.0 | 2023-05-06 |
2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Related Literature
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
Additional information on 2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Recent Advances in the Study of 2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAS: 2223032-20-8)
The compound 2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAS: 2223032-20-8) has recently garnered significant attention in the field of chemical biology and medicinal chemistry. This boronic ester derivative is a key intermediate in the synthesis of various bioactive molecules, particularly in the development of boron-containing therapeutics. Its unique chemical properties, including stability and reactivity, make it a valuable building block for drug discovery and development.
Recent studies have focused on the application of this compound in Suzuki-Miyaura cross-coupling reactions, a pivotal method for constructing carbon-carbon bonds in pharmaceutical synthesis. Researchers have demonstrated its efficacy in producing complex heterocyclic structures, which are often found in drugs targeting cancer, infectious diseases, and neurological disorders. The compound's ability to act as a boron donor has also been explored in the context of boron neutron capture therapy (BNCT), a promising approach for treating certain types of cancer.
In a 2023 study published in the Journal of Medicinal Chemistry, scientists utilized 2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane to synthesize a series of novel kinase inhibitors. The results indicated high selectivity and potency against specific oncogenic kinases, with minimal off-target effects. This highlights the compound's potential in the development of targeted cancer therapies. Additionally, its role in the synthesis of boron-doped nanomaterials for drug delivery systems has been investigated, offering new avenues for enhancing therapeutic efficacy and reducing systemic toxicity.
Further research has explored the pharmacokinetic and toxicological profiles of derivatives derived from this boronic ester. Preliminary findings suggest favorable bioavailability and metabolic stability, although further in vivo studies are required to fully assess its safety and efficacy. The compound's versatility and compatibility with various synthetic protocols underscore its importance in modern medicinal chemistry.
In conclusion, 2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAS: 2223032-20-8) represents a critical tool in the advancement of boron-based therapeutics. Its applications span from synthetic chemistry to drug development, offering promising solutions for unmet medical needs. Future research should focus on optimizing its derivatives for clinical use and exploring its potential in other therapeutic areas.
2223032-20-8 (2-(5-Ethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)